About Merus Labs International
Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: TSE
- Symbol: MSL
- Previous Close: $1.14
- 50 Day Moving Average: $1.09
- 200 Day Moving Average: $1.23
- 52-Week Range: C$0.95 - C$2.20
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $133.77M
- Outstanding Shares: 117,345,000
Earnings History for Merus Labs International (TSE:MSL)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Merus Labs International (TSE:MSL)
Current Year EPS Consensus Estimate: $-0.05 EPS
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Merus Labs International (TSE:MSL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Merus Labs International (TSE:MSL)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Latest Headlines for Merus Labs International (TSE:MSL)
What is Merus Labs International's stock symbol?
Merus Labs International trades on the Tornton Stock Exchange (TSX) under the ticker symbol "MSL."
Where is Merus Labs International's stock going? Where will Merus Labs International's stock price be in 2017?
6 brokerages have issued twelve-month target prices for Merus Labs International's shares. Their forecasts range from C$1.00 to C$3.00. On average, they expect Merus Labs International's share price to reach C$2.11 in the next year.
When will Merus Labs International announce their earnings?
Merus Labs International is scheduled to release their next quarterly earnings announcement on Tuesday, May, 9th 2017.
How do I buy Merus Labs International stock?
Shares of Merus Labs International and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How much does a share of Merus Labs International stock cost?
One share of Merus Labs International stock can currently be purchased for approximately C$1.14.
Merus Labs International (TSE:MSL) Chart for Wednesday, March, 1, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart